AltruBio is developing first-in-class immune-modulators to target diseases of the immune system. Its world-class global team brings a breadth of expertise in immunology and drug development to bring their biologic treatments to patients.
AltruBio is committed to the development of innovative treatments and prevention against inflammatory/autoimmune disease. Through the advancement of its technology platforms, AltruBio aims to create better therapies for patients with immune diseases.